CDON | Cell adhesion associated, oncogene regulated | Disease related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CMTM4 | CKLF-like MARVEL transmembrane domain containing 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
DCDC2 | Doublecortin domain containing 2 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
GPR61 | G protein-coupled receptor 61 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ITGB3 | Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
KCNAB1 | Potassium voltage-gated channel, shaker-related subfamily, beta member 1 | Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCTD8 | Potassium channel tetramerization domain containing 8 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
KHDRBS2 | KH domain containing, RNA binding, signal transduction associated 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
KLHL14 | Kelch-like family member 14 | Predicted intracellular proteins
| | | | | Tissue enhanced |
KRT7 | Keratin 7 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
LPCAT2 | Lysophosphatidylcholine acyltransferase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NPM2 | Nucleophosmin/nucleoplasmin 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
NPNT | Nephronectin | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NTRK2 | Neurotrophic tyrosine kinase, receptor, type 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
OCLN | Occludin | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
PDE1A | Phosphodiesterase 1A, calmodulin-dependent | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
PRTG | Protogenin | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SALL4 | Spalt-like transcription factor 4 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
SSC4D | Scavenger receptor cysteine rich family, 4 domains | Predicted secreted proteins
| | | | | Tissue enhanced |
TFF3 | Trefoil factor 3 (intestinal) | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |